USPTO serial 90888994
EMERGENT
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jun 3, 2025
- Examiner
- MURRAY, DAVID T
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with EMERGENT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Virginia Wolk Marino
Virginia Wolk Marino Crowell & Moring LLPP.O. BOX 10395CHICAGO, IL 60610United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the treatment and prophylaxis of biological infection, exposure, and contamination; pharmaceutical preparations for the treatment and prophylaxis of chemical, radiological and nuclear exposure and contamination; pharmaceutical preparations for the treatment and prophylaxis of infectious diseases; pharmaceutical products for use in biodefense, namely, pharmaceutical preparations to protect people against the effects of biological agents or bioterrorism | ACTIVE | May 24, 2022 |
| 040 | Contract manufacturing in the field of pharmaceuticals; fill and finishing services, namely, clinical manufacturing of drug formulations for others to support clinical trials, commercial manufacturing for others and lyophilization, namely, freeze-drying services for others, in the field of pharmaceuticals | ACTIVE | May 24, 2022 |
| 042 | Research and development in the pharmaceutical, biotechnology, and biodefense fields; Research and development of pharmaceutical preparations and medicines as a Contract Development Manufacturing Operation | ACTIVE | May 24, 2022 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Emergent BioSolutions Inc.
- Other trademarks owned by Emergent BioSolutions Inc.
- Other trademarks owned by Emergent BioSolutions Inc.
- Other trademarks in Class 005
- Other trademarks in Class 040
- Other trademarks in Class 042
- Similar marks named EMERGENT
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 3, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jun 3, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 11, 2025 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| May 11, 2025 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| May 10, 2025 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| May 10, 2025 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Feb 20, 2025 | IUAF | USE AMENDMENT FILED | — |
| Feb 20, 2025 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Sep 18, 2024 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Aug 15, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Aug 15, 2024 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Aug 15, 2024 | EXT4 | SOU EXTENSION 4 FILED | — |
| Aug 15, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 24, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Feb 23, 2024 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Feb 23, 2024 | EXT3 | SOU EXTENSION 3 FILED | — |
| Feb 23, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jan 22, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jan 22, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 22, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jan 22, 2024 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jan 22, 2024 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Aug 10, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Aug 8, 2023 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Aug 8, 2023 | EXT2 | SOU EXTENSION 2 FILED | — |
| Aug 8, 2023 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 3, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 23, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Feb 21, 2023 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Feb 21, 2023 | EXT1 | SOU EXTENSION 1 FILED | — |
| Feb 21, 2023 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Aug 23, 2022 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jun 28, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 28, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 8, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 25, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 25, 2022 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| May 25, 2022 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| May 25, 2022 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| May 25, 2022 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| May 19, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 22, 2022 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Feb 22, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Feb 22, 2022 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Oct 6, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 21, 2021 | NWAP | NEW APPLICATION ENTERED | — |